Title : Ephedrine as a lead compound for the development of new DPP-IV inhibitors - Ojeda-Montes_2017_Future.Med.Chem_9_2129 |
Author(s) : Ojeda-Montes MJ , Ardid-Ruiz A , Tomas-Hernandez S , Gimeno A , Cereto-Massague A , Beltran-Debon R , Mulero M , Garcia-Vallve S , Pujadas G , Valls C |
Ref : Future Med Chem , 9 :2129 , 2017 |
Abstract : Ojeda-Montes_2017_Future.Med.Chem_9_2129 |
ESTHER : Ojeda-Montes_2017_Future.Med.Chem_9_2129 |
PubMedSearch : Ojeda-Montes_2017_Future.Med.Chem_9_2129 |
PubMedID: 29172693 |
Ojeda-Montes MJ, Ardid-Ruiz A, Tomas-Hernandez S, Gimeno A, Cereto-Massague A, Beltran-Debon R, Mulero M, Garcia-Vallve S, Pujadas G, Valls C (2017)
Ephedrine as a lead compound for the development of new DPP-IV inhibitors
Future Med Chem
9 :2129
Ojeda-Montes MJ, Ardid-Ruiz A, Tomas-Hernandez S, Gimeno A, Cereto-Massague A, Beltran-Debon R, Mulero M, Garcia-Vallve S, Pujadas G, Valls C (2017)
Future Med Chem
9 :2129